Lipid Nanoparticles Immunogenicity and Toxicity
Evvnt Promotion / evvnt
Archiv
06.12.2022 - 08.12.2022 Hyatt Regency Boston, 1 Avenue de Lafayette, Massachusetts, 02111 Boston, USA
Time: 09:00 to 16:00
Kongressthemen
Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency
Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response.
Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency
Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response.
Kongressorganizer (PCO)
Molly Sullivan
Molly Sullivan
Anmerkungen
Brochure: https://go.evvnt.com/1289158-3?pid=4832
Speakers: Vibha Jawa, Executive Director, Bristol Myers Squibb, Tao Niu, Associate Director, Modeling and Simulations, Vertex Pharmaceuticals, and more
Brochure: https://go.evvnt.com/1289158-3?pid=4832
Speakers: Vibha Jawa, Executive Director, Bristol Myers Squibb, Tao Niu, Associate Director, Modeling and Simulations, Vertex Pharmaceuticals, and more
Anfragen und Anmeldung:
https://go.evvnt.com/1289158-2?pid=4832
Frau Molly Sullivan
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
